Citigroup
ERNA icon

Citigroup’s Eterna Therapeutics ERNA Stock Holding History

Citigroup’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-408
Closed -$27.3K – 5721
2025
Q1 		$27.3K Buy
+408
New +$50.3K ﹤0.01% 5025
2024
Q4 		– Hold
0
– – – 5790
2024
Q3 		– Hold
0
– – – 5600
2024
Q2 		– Hold
0
– – – 5489
2024
Q1 		– Hold
0
– – – 5531
2023
Q4 		– Hold
0
– – – 5608
2023
Q3 		– Hold
0
– – – 5556
2023
Q2 		– Hold
0
– – – 5487
2023
Q1 		– Hold
0
– – – 5324
2022
Q4 		– Hold
0
– – – 5669
2022
Q3 		– Hold
0
– – – 5962
2022
Q2 		– Hold
0
– – – 6013
2022
Q1 		– Sell
-1
Closed -$19K – 5808
2021
Q4 		$39K Buy
+1
New +$54.4K ﹤0.01% 5185
2021
Q3 		– Hold
0
– – – 4940
2021
Q2 		– Hold
0
– – – 5154
2015
Q1 		– Hold
0
– – – 7246
2014
Q4 		– Hold
0
– – – 7153
2014
Q3 		– Hold
0
– -$1K – 7118
2014
Q2 		– Hold
0
– – – 6901

Other funds holding ERNA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
SCA
Sippican Capital Advisors Boston, Massachusetts $164M AUM 35.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $3.28B AUM 23.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup's ERNA Position: Q2 2025 in Review

Citigroup sold out of Eterna Therapeutics (ERNA) in Q2 2025, closing a stake of 408 shares — an estimated $27.3K sold.

Citigroup first reported a position in ERNA in Q4 2021 and held it in 2 quarters. The position peaked at $39K in Q4 2021. 9 funds tracked by Wall St. Rank hold ERNA as of Q2 2025.

  • Citigroup reported no remaining Eterna Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Citigroup sold 408 Eterna Therapeutics shares in Q2 2025, an estimated $27.3K.
  • Citigroup first reported a position in Eterna Therapeutics in Q4 2021 and held it in 2 quarters.
  • Citigroup's Eterna Therapeutics position peaked at $39K in Q4 2021.
  • 9 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2025.

Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.